Loading…
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally. The company synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection, such as insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms. It distributes its products through national distribution companies, buying groups, or co-operatives, as well as through sales offices, wholly owned distributors, sales force executives, and sales agents. American Vanguard Corporation was incorporated in 1969 and is headquartered in Newport Beach, California.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $515M | $-12M | $-50M | $-25M | -25.9% | -5.9% | - |
| 2024 | $547M | $-82M | $-126M | $-4M | -54.2% | -5.5% | -1780.3% |
| 2023 | $579M | $45M | $8M | $-71M | 2.0% | -5.0% | -72.6% |
| 2022 | $610M | $62M | $27M | $43M | 7.4% | - | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total Revenue | 609.62 | 579.37 | 547.31 | 515.11 |
| Cost Of Revenue | 417.23 | 400.21 | 426.99 | 367.55 |
| Gross Profit | 192.39 | 179.16 | 120.32 | 147.56 |
| Operating Expense | 151.74 | 154.91 | 151.11 | 133.79 |
| Operating Income | 40.65 | 24.25 | -30.79 | 13.77 |
| EBITDA | 62.06 | 44.72 | -81.59 | -11.79 |
| EBIT | 39.92 | 22.94 | -103.91 | -30.53 |
| Pretax Income | 35.97 | 10.30 | -120.46 | -47.20 |
| Tax Provision | 8.56 | 2.78 | 5.88 | 2.68 |
| Net Income | 27.40 | 7.52 | -126.34 | -49.88 |
| Net Income Common Stockholders | 27.40 | 7.52 | -126.34 | -49.88 |
| Total Expenses | 568.96 | 555.12 | 578.10 | 501.35 |
| Interest Expense | 3.95 | 12.64 | 16.55 | 16.67 |
| Interest Income | 0.17 | 0.37 | 0 | 0.11 |
| Research And Development | 31.82 | 38.02 | 32.66 | 23.16 |
| Selling General And Administration | 119.92 | 116.89 | 105.11 | 98.51 |
| Normalized EBITDA | 62.79 | 46.03 | -8.47 | 30.71 |
| Normalized Income | 27.96 | 8.48 | -68.58 | -16.31 |
| Basic EPS | 0.94 | 0.27 | -4.50 | 0 |
| Diluted EPS | 0.92 | 0.26 | -4.50 | 0 |
| Tax Effect Of Unusual Items | -0.17 | -0.36 | -15.35 | -8.93 |
| Tax Rate For Calcs | 0.24 | 0.27 | 0.21 | 0.21 |
| Total Unusual Items | -0.73 | -1.32 | -73.12 | -42.50 |
| Total Unusual Items Excluding Goodwill | -0.73 | -1.32 | -73.12 | -42.50 |
| Net Income From Continuing Operation Net Minority Interest | 27.40 | 7.52 | -126.34 | -49.88 |
| Reconciled Depreciation | 22.14 | 21.78 | 22.32 | 18.74 |
| Reconciled Cost Of Revenue | 417.23 | 400.21 | 418.01 | 360.93 |
| Net Interest Income | -3.95 | -12.64 | -16.55 | -18.47 |
| Net Income From Continuing And Discontinued Operation | 27.40 | 7.52 | -126.34 | -49.88 |
| Total Operating Income As Reported | 40.65 | 23.30 | -101.56 | -28.30 |
| Diluted Average Shares | 29.87 | 28.53 | 28.06 | 0 |
| Basic Average Shares | 29.23 | 28.13 | 28.06 | 0 |
| Diluted NI Availto Com Stockholders | 27.40 | 7.52 | -126.34 | -49.88 |
| Net Income Including Noncontrolling Interests | 27.40 | 7.52 | -126.34 | -49.88 |
| Net Income Continuous Operations | 27.40 | 7.52 | -126.34 | -49.88 |
| Earnings From Equity Interest Net Of Tax | 0 | 0 | 0 | 0 |
| Other Income Expense | -0.73 | -1.32 | -73.12 | -42.50 |
| Other Non Operating Income Expenses | 0 | 0 | 0 | 0 |
| Special Income Charges | 0 | -0.96 | -70.76 | -42.06 |
| Gain On Sale Of Ppe | 0 | 0 | 1 | 0.25 |
| Other Special Charges | 0 | 0 | 1.19 | 9.73 |
| Impairment Of Capital Assets | 0 | 0 | 50.41 | 25.39 |
| Restructuring And Mergern Acquisition | 0 | 0.96 | 20.16 | 7.19 |
| Gain On Sale Of Security | -0.73 | -0.36 | -2.36 | -0.44 |
| Net Non Operating Interest Income Expense | -3.95 | -12.64 | -16.55 | -18.47 |
| Total Other Finance Cost | 0.29 | 0.26 | 0 | 1.91 |
| Interest Expense Non Operating | 3.95 | 12.64 | 16.55 | 16.67 |
| Interest Income Non Operating | 0.17 | 0.37 | 0 | 0.11 |
| Other Operating Expenses | 0 | 0.96 | 20.16 | 0 |
| Depreciation Amortization Depletion Income Statement | 13.95 | 13.28 | 13.34 | 12.12 |
| Depreciation And Amortization In Income Statement | 13.95 | 13.28 | 13.34 | 12.12 |
| Amortization | 13.95 | 13.28 | 13.34 | 12.12 |
| Amortization Of Intangibles Income Statement | 13.95 | 13.28 | 13.34 | 12.12 |
| Selling And Marketing Expense | 101.48 | 56.02 | 48.73 | 45.43 |
| General And Administrative Expense | 53.46 | 48.55 | 56.38 | 53.08 |
| Other Gand A | 53.46 | 48.55 | 56.38 | 53.08 |
| Operating Revenue | 609.62 | 579.37 | 547.31 | 515.11 |
Basic Materials sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| American Vanguard Corporationthis co. | AVD | $81M | - | 0.43 | -25.9% | 11.42 |
| Core Molding Technologies, Inc. | CMT | $252M | 21.23 | 1.47 | 7.1% | 8.18 |
| Clearwater Paper Corporation | CLW | $208M | - | 0.25 | -2.3% | 5.43 |
| Montauk Renewables, Inc. | MNTK | $206M | 144.00 | 0.79 | 0.7% | 8.84 |
| FutureFuel Corp. | FF | $198M |
| - |
| 1.28 |
| -31.9% |
| -3.38 |
| Smith-Midland Corporation | SMID | $176M | 14.05 | 3.24 | 23.0% | 8.48 |
| Friedman Industries, Incorporated | FRD | $142M | 8.96 | 1.00 | 4.6% | 10.15 |
| Ascent Industries Co. | ACNT | $134M | - | 1.57 | 1.0% | -33.80 |
| Trinseo PLC | TSEOF | $4M | - | -0.00 | 49.7% | 13.80 |
| Peer Median | - | 17.64 | 1.14 | 2.8% | 8.33 | |